| Literature DB >> 33511957 |
Vyacheslav Ogay1, Aliya Sekenova1, Yelena Li2, Assel Issabekova2, Arman Saparov3.
Abstract
Atherosclerosis is a multifactorial and complex disease involving the arterial intima of the circulatory system. The main risk factors of atherosclerosis are diabetes mellitus, hypertension, hyperlipidemic states, smoking, mental stress, unhealthy diet and a lack of physical activity. Recent studies have shown that dyslipidemia, inflammation and immune cells are involved in all stages of development of atherosclerosis. Mesenchymal stem cells are a heterogeneous subset of multipotent cells that can be isolated from nearly all human organs and tissues, and they possess both regenerative and immunomodulatory properties. Recent studies have shown that mesenchymal stem cells are able to provide immunosuppressive, regenerative and atheroprotective effects by reducing dyslipidemia, inflammation, and inhibiting endothelial cell dysfunction and plaque formation during the development of atherosclerosis in animal models. Based on these beneficial effects, mesenchymal stem cells are considered a promising alternative therapeutic approach for effective treatment of atherosclerosis. In this review, we summarize the current findings on potential applications of mesenchymal stem cells for preventing and regressing atherosclerosis as well as discuss strategies for improving the efficacy of mesenchymal stem cell-based therapy. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Mesenchymal stem cells; atherosclerosis; autophagy.; genetic modification; mesenchymal stem cell-based therapy; preconditioning
Year: 2021 PMID: 33511957 DOI: 10.2174/1574888X16999210128193549
Source DB: PubMed Journal: Curr Stem Cell Res Ther ISSN: 1574-888X Impact factor: 3.828